STipe Therapeutics (private company)

STipe Therapeutics is a biotechnology company with a vision to become a leader in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer.

Companies with similar profile to STipe Therapeutics:

Company	Criteria
Galecto Biotech 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
OxThera 66%	Similar verticals: Biotech, Pharma Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Forendo Pharma 66%	Similar verticals: Health services, Pharma Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Orphazyme 65%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures At least one other investor: Novo A/S Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
MinervaX 56%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD
Acarix 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Snipr Biome 55%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Wellington Partners Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
NMD Pharma 54%	Similar verticals: Biotech, Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Aprea Therapeutics 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Alvotech 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Asarina Pharma 54%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
AFYX Therapeutics 54%	Similar verticals: Biotech, Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Mobidiag 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Unibio 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
ITBMed 54%	Similar verticals: Biotech, Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Oncoinvent 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
InProTher 44%	Similar verticals: Biotech, Health services Similar business models: B2B At least one other investor: Novo A/S
TILT Biotherapeutics 44%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD
Vaccibody 44%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD
Optomed 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes